CONCORD MEDICAL - SPON ADR (CCM)

US2062771058 - ADR

0.63  -0.07 (-10%)

After market: 0.6536 +0.02 (+3.75%)

Fundamental Rating

0

Taking everything into account, CCM scores 0 out of 10 in our fundamental rating. CCM was compared to 117 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of CCM have multiple concerns. CCM is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

CCM had negative earnings in the past year.
In the past 5 years CCM always reported negative net income.
In the past 5 years CCM always reported negative operating cash flow.

1.2 Ratios

CCM's Return On Assets of -7.68% is on the low side compared to the rest of the industry. CCM is outperformed by 62.07% of its industry peers.
Industry RankSector Rank
ROA -7.68%
ROE N/A
ROIC N/A
ROA(3y)-6.11%
ROA(5y)-6.12%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CCM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

CCM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CCM has about the same amount of shares outstanding.
Compared to 5 years ago, CCM has about the same amount of shares outstanding.
The debt/assets ratio for CCM is higher compared to a year ago.

2.2 Solvency

CCM has an Altman-Z score of -1.14. This is a bad value and indicates that CCM is not financially healthy and even has some risk of bankruptcy.
CCM has a worse Altman-Z score (-1.14) than 73.28% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.14
ROIC/WACCN/A
WACC4.9%

2.3 Liquidity

CCM has a Current Ratio of 0.64. This is a bad value and indicates that CCM is not financially healthy enough and could expect problems in meeting its short term obligations.
CCM has a Current ratio of 0.64. This is amonst the worse of the industry: CCM underperforms 85.34% of its industry peers.
CCM has a Quick Ratio of 0.64. This is a bad value and indicates that CCM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.60, CCM is doing worse than 81.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.6

2

3. Growth

3.1 Past

The earnings per share for CCM have decreased strongly by -57.56% in the last year.
CCM shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.12%.
The Revenue has been growing slightly by 7.36% on average over the past years.
EPS 1Y (TTM)-57.56%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q20.64%
Revenue 1Y (TTM)40.12%
Revenue growth 3Y33.5%
Revenue growth 5Y7.36%
Revenue growth Q2Q97.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

CCM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CCM!.
Industry RankSector Rank
Dividend Yield N/A

CONCORD MEDICAL - SPON ADR

NYSE:CCM (5/3/2024, 7:04:00 PM)

After market: 0.6536 +0.02 (+3.75%)

0.63

-0.07 (-10%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap27.35M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.68%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.64
Quick Ratio 0.6
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-57.56%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)40.12%
Revenue growth 3Y33.5%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y